文献速递脑血管病外科神经重症

持续高渗盐水治疗急性缺血性梗死的影像与临床评估

Effectiveness of Continuous Hypertonic Saline in Acute Ischemic Infarcts: A Radiographic and Clinical Evaluation.
PubMed 文献 · World Neurosurg · 2021-08-27

本研究回顾性比较了43例大面积前循环梗死患者,其中26例接受持续高渗盐水(HS)治疗、17例接受常规内科管理。两组在手术率与时机、并发症及死亡率上无差异,但HS组在12-36小时(P=0.003)和36-60小时(P=0.030)的平均中线移位显著更大,初始至第一时段的平均中线移位变化也显著更大(P=0.019)。结论提示持续HS无获益,甚至可能加重脑水肿。

要点

  • 持续高渗盐水未降低大面积梗死患者的手术率、并发症或死亡率。
  • HS组在12-36小时与36-60小时的中线移位显著大于对照组。
  • HS组中线移位从初始到12-36小时的变化显著更大,提示水肿可能加重。

核心结论

  • 持续HS在大面积前循环梗死中无获益,且可能加重脑水肿,对减压手术的预防或延迟及总体死亡率无影响。

研究设计与样本

  • 回顾性研究,纳入43例恶性缺血性卒中患者,26例初始接受持续HS治疗(组1),17例接受常规内科管理(组2)。
  • 收集入院后不同时间点的脑水肿影像学参数与临床参数,并记录手术率与时机、死亡率及并发症。

主要发现

  • 两组基线临床与影像学参数相当。
  • 两组手术率与时机、并发症及死亡率无差异。
  • HS组平均中线移位在12-36小时(P=0.003)和36-60小时(P=0.030)显著更大。
  • HS组初始至12-36小时的平均中线移位变化显著更大(P=0.019)。

临床怎么用

  • 对大面积前循环梗死合并恶性脑水肿患者,不应常规以持续HS作为减轻水肿或避免减压手术的手段。
  • 使用持续HS时需警惕影像学上中线移位加重,密切随访影像与神经功能。

局限性

  • 为单中心回顾性研究,样本量仅43例,HS组与对照组例数不均衡。
  • 评估持续HS对影像学进展与减压手术率影响的既往研究极为有限,结论需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The role of continuous hypertonic saline (HS) infusion in the management of malignant cerebral edema is controversial. We evaluated patients presenting with large anterior circulation territory infarcts and compared radiographic and clinical outcomes to evaluate the effects of continuous HS. METHODS: This was a retrospective review of patients with malignant ischemic strokes who were initially managed with continuous HS versus routine medical management. Radiographic parameters of cerebral edema and clinical parameters were collected at different time intervals after admission. Rates and timing of surgery, mortality, and complications were also collected. RESULTS: The study included 43 patients: 26 in group 1 (HS) and 17 in group 2 (no HS). Both cohorts had comparable baseline clinical and radiographic parameters. There was no difference between rates and timing of surgery, complications, and mortality. Mean midline shift was significantly greater in the HS group at interval 1 (12-36 hours, P = 0.003) and interval 2 (36-60 hours, P = 0.030), and mean change in midline shift from initial interval to interval 1 was significantly greater in the HS group (P = 0.019). CONCLUSIONS: Despite the widespread use of continuous HS in acute ischemic infarcts, only a limited number of studies have evaluated its efficacy, and virtually no studies have studied its effect on radiographic progression and rates of decompressive surgery. Results of this study indicate that there is no benefit of continuous HS. In fact, there may be worsening of cerebral edema with administration of continuous HS. In addition, there are no differences in prevention or delay of decompressive surgery or in overall mortality.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Chugh AJS, Sunshine K, Srivatsa S, et al. Effectiveness of Continuous Hypertonic Saline in Acute Ischemic Infarcts: A Radiographic and Clinical Evaluation. World Neurosurg. 2021. PMID: 34461281. doi:10.1016/j.wneu.2021.08.086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。